Heron Therapeutics
As of the edition of 20 October 2026, Heron Therapeutics runs 8 drugs, 2 of them marketed.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Marketed | 2 |
| Went quiet | 5 |
| Stopped | 1 |
| Total | 8 |
Marketed drugs and when their US protection ends
| Drug | US protection | Route B rows |
|---|---|---|
| Aprepitant | none listed | 2 |
| Granisetron | none listed | 2 |
A route B row is one company at one target.
Where its trials are
- Nervous system: 9 trials led
- Bones, joints and muscles: 4 trials led